Celyad - News

Corporate › Regulated September 16, 2019

Celyad Announces Closing of $20 Million Global Offering

Corporate › Regulated September 12, 2019

Celyad Announces Pricing of $20.0 Million Global Offering

Corporate › Regulated September 10, 2019

Celyad Announces Launch of Proposed Global Offering

Corporate › Regulated August 22, 2019

Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights

Corporate › Regulated May 09, 2019

Celyad Announces First Quarter 2019 Financial Results and Recent Business Highlights

Corporate › Regulated March 28, 2019

Celyad Reports Business Update and Full Year 2018 Financial and Operating Results

Corporate › Regulated March 28, 2019

Celyad Appoints Filippo Petti as Chief Executive Officer

Corporate › Regulated November 21, 2018

Celyad Announces Third Quarter 2018 Business Update

Corporate › Regulated November 09, 2018

Celyad Presents Update on CYAD-01 Solid Tumor Clinical Program at the SITC 33rd Annual Meeting

Corporate › Regulated November 01, 2018

Celyad to Present New CYAD-01 Data from THINK Study in Relapsed/Refractory Acute Myeloid Leukemia at 2018 ASH Annual Meeting

Corporate › Regulated October 04, 2018

Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop Next-Generation Allogeneic CAR-T Therapies

Corporate › Regulated September 28, 2018

Transparency notification of Victory Capital Management Inc. (Article 14 of the Law of 2 May 2007)